Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors
- 1 December 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (23) , 6476-6480
- https://doi.org/10.1016/j.bmcl.2007.09.090
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 DiabetesCurrent Topics in Medicinal Chemistry, 2007
- Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?Regulatory Peptides, 2005
- What do we know about the secretion and degradation of incretin hormones?Regulatory Peptides, 2005
- Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetesDrug Discovery Today, 2005
- Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitterRegulatory Peptides, 2004
- Glycaemic effects of incretins in Type 1 diabetes mellitusRegulatory Peptides, 2004
- 1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic PropertiesJournal of Medicinal Chemistry, 2003
- Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group studyThe Lancet, 2002
- Biological actions and therapeutic potential of the glucagon-like peptidesGastroenterology, 2002
- Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDMDiabetologia, 1996